News from the Nucleic Acid Chemistry Center at UMass Chan Medical School

UMass Chan scientists have received funding to explore gene editing technologies for treating frontotemporal dementia.

Caterina Strambio De Castillia, PhD, received a four-year, $4 million National Science Foundation grant to support her project, Imaging-PHD. 

UMass Chan Medical licenses exNA oligonucleotide technology to Hongene Biotech Corporation

Eleven teams of medical students, faculty members, residents and staff are the recipients of the 2025 Remillard Family Community Service Fund grants.

Gov. Healey introduced the Discovery, Research & Innovation for a Vibrant Economy initiative.

UMass Chan licenses potential RNA-based treatment for fragile X syndrome to QurAlis Corporation.

A siRNA therapeutic for dermatological diseases developed at UMass Chan Medical School has entered the clinical trial phase.

This special edition of @umasschan magazine celebrates Victor Ambros, PhD, the newest Nobel laureate at UMass Chan Medical School.

Anastasia Khvorova, PhD, has been awarded the 2025 Else Kröner Fresenius Prize for Medical Research.

UMass Chan supports translational research from faculty with internal funding mechanism.